Elsevier closes Interfolio acquisition

Elsevier, a global leader in research publishing and information analytics, and part of RELXopens in new tab/window, has closed the acquisition of Interfolioopens in new tab/window, a provider of advanced faculty information solutions for higher education, headquartered in Washington DC, US.

For over 20 years, Interfolio has supported academics, researchers, higher education institutions and funders. Interfolio’s portfolio includes Faculty Information System (FIS)opens in new tab/window, Dossier, and Researchfishopens in new tab/window. Faculty Information System enables academics to collect and manage critical data for academic hiring, review, promotion and tenure, through a streamlined and transparent digital process, using faculty activity data which benefits the scholar and the institution. Researchfish technology helps funders and research organisations to collect, track, assess, and gain deep insights into research outputs, outcomes and impacts. Dossier helps individual scholars and researchers to aggregate and efficiently apply for faculty positions and graduate programs.

Andrew Rosen, Chief Executive Officer at Interfolio, said: “I am incredibly proud of everyone at Interfolio. We have a singular focus: helping our customers to understand and effectively manage the huge amount of activity that scholars accomplish. As part of Elsevier, we will retain this focus and strengthen our core products for our customers. We will aim to support more institutions internationally, increase data automation to help our customers improve efficiency, and provide sophisticated analytics tools to expand insights and facilitate scholarly work. This is an exciting next step for our business, and I look forward to working with the Elsevier team.”

Interfolio will be part of Elsevier’s Research Intelligence portfolio, which includes

 Scopus, SciValopens in new tab/window, Pure and Digital Commons.opens in new tab/window The combined portfolio will deliver analysis and insights that help academic researchers, research leaders, institutions and funders achieve their strategic goals.

Theo Pillay, General Manager of Research Institutional Products at Elsevier, said: “Interfolio has an unparalleled understanding of scholarly faculty activity and managing research assessment data. Its solutions will strengthen our Research Intelligence portfolio and there are strong synergies that will help us deliver increased and accelerated value to both Elsevier and Interfolio customers and users. I am very pleased to welcome the Interfolio team to Elsevier.”

Macquarie Capital served as exclusive financial advisor to Interfolio.

---

About Interfolio

Conceived by academics for academics, Interfolio is an education technology company headquartered in Washington, DC, US. Founded in 1999, Interfolio serves colleges and universities, funders and research organizations, and individual scholars. More than 400 clients based in 25 countries choose Interfolio’s solutions for hiring and recruitment, academic appointments and timelines, activity data reporting, faculty reviews and promotions, and research impact analysis. Interfolio provides scholar-first products for the full academic lifecycle—from job seeking to professional accomplishments, committee service, funding award compliance, career growth and advancement, administrative leadership, and beyond. For more information about Interfolio, please visit www.interfolio.comopens in new tab/window.

About RELX

RELX is a global provider of information-based analytics and decision tools for professional and business customers. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs more than 33,000 people over 40% of whom are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York stock exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalisation is approximately £43.2bn/ €50.7bn/ $54.4bn.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.